Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Bryan Caskey

Physician Assistant Beckley, WV Physician Assistant

NPI 1366582660 CMS profile 11140195

94 Brookshire Ln, Beckley, WV 25801

Open in the dashboard

General payments

$3,358

235 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Bryan Caskey of Beckley, WV is reported in the CMS Open Payments database as having received $3,358 across 235 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $775 70
2024 General $732 42
2023 General $792 50
2022 General $515 42
2021 General $545 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bryan Caskey
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Bryan Caskey were reported at $775. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Bryan Caskey Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $545 $132 $37–$438 $132
2022 $515 $155 $48–$522 $149
2023 $792 $167 $52–$557 $160
2024 $732 $178 $55–$600 $164
2025 $775 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Janssen Biotech, Inc. $1,406 98 payments
  2. AbbVie, Inc. $1,045 84 payments
  3. E.R. Squibb & Sons, L.L.C. $208 16 payments
  4. Sun Pharmaceutical Industries Inc. $159 11 payments
  5. Lilly USA, LLC $143 7 payments
  6. Organogenesis Inc. $88 5 payments
  7. Janssen Scientific Affairs, LLC $76 1 payment
  8. Dermavant Sciences, Inc. $58 3 payments
  9. Incyte Corporation $26 2 payments
  10. Galderma Laboratories, L.P. $23 1 payment
  11. Other $125 7 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,358 235 payments
Products named General payments · program years 2021–2025
  1. TREMFYA $1,448 97 payments
  2. SKYRIZI Immunology $516 35 payments
  3. RINVOQ $378 32 payments
  4. SOTYKTU $208 16 payments
  5. TALTZ $143 7 payments
  6. SKYRIZI Immunology $129 12 payments
  7. ILUMYA $115 8 payments
  8. Puraply $88 5 payments
  9. VTAMA $58 3 payments
  10. BLU-U $44 3 payments
  11. Other $444 30 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

619

Median for Physician Assistant: 241

Drug cost

$101,769

Median for Physician Assistant: $4,110

Branded share of claims

1.9%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cosentyx Sensoready (2 Pens) Secukinumab Brand 12 $86,831
Clobetasol Propionate Generic 55 $3,771
Metronidazole Generic 21 $2,290
Ketoconazole Generic 98 $1,768
Triamcinolone Acetonide Generic 126 $1,753
Doxycycline Hyclate Generic 95 $1,413
Ammonium Lactate Generic 40 $1,058
Fluorouracil Generic 13 $942
Betamethasone Dipropionate Generic 14 $569
Clindamycin Phosphate Generic 12 $463

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 94 billing codes

Paid by Medicare

$334,356

Of which drugs: $16,299

Medicare patients

957

Average age 76

Services billed

2,977

451 women, 506 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 43%
Diabetes 36%
Ischemic heart disease 31%
Chronic kidney disease 24%
COPD 20%
Atrial fibrillation 19%
Depression 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 15 49 $220

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

5 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
TREMFYA
  • Janssen Biotech, Inc. $578
$578 — —
RINVOQ
  • AbbVie, Inc. $51
$51 — —
VTAMA
  • Dermavant Sciences, Inc. $41
$41 — —
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $32
$32 — —
Odomzo
  • Sun Pharmaceutical Industries Inc. $15
$15 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

235 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record